Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,774.50
Ask: 1,775.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.056%)
Open: 1,775.50
High: 1,778.50
Low: 1,769.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Dividends Calendar - Week Ahead

Fri, 04th Apr 2014 05:32

UK Dividends Calendar 
Friday, April 4 
AvivaRecord date for 2013 dividend
TreattPayment date for 2013 dividend
St. Modwen PropertyPayment date for 2013 dividend
BlackRock Throgmorton TrustPayment date for 2013 dividend
MJ GleesonPayment date for 2014 dividend
Domino's Pizza GroupPayment date for 2013 dividend
Go-Ahead GroupPayment date for 2014 dividend
Murray Income Trust (Ord)Payment date for 2014 dividend
Small Companies Dividend TrustPayment date for 2013 dividend
Asian Total Return Investment CompanyPayment date for 2013 dividend
Monday, April 7 
DiageoPayment date for 2014 dividend
Electronic Data ProcessingPayment date for 2013 dividend
Oxford InstrumentsPayment date for 2014 dividend
PZ CussonsPayment date for 2014 dividend
RenishawPayment date for 2014 dividend
RicardoPayment date for 2014 dividend
Standard Life UK Smaller Companies TrustPayment date for 2014 dividend
JPMorgan European Investment TrustPayment date for 2014 dividend
Eurocastle InvestmentEx-dividend date 2014
Tuesday, April 8Payment date for 2013 dividend
Alumasc GroupPayment date for 2014 dividend
CarcloPayment date for 2014 dividend
Dechra PharmaceuticalsPayment date for 2014 dividend
Independent Investment TrustPayment date for 2013 dividend
ShirePayment date for 2013 dividend
Independent Investment TrustSpecial dividend payment date
Wednesday, April 9 
Henderson International Income TrustEx-dividend date 2014
Standard LifeEx-dividend date 2013
HaysPayment date for 2014 dividend
Jupiter Fund ManagementEx-dividend date 2013
International Personal FinanceEx-dividend date 2013
4imprint GroupEx-dividend date 2013
JPMorgan Mid Cap Investment TrustPayment date for 2014 dividend
Assura GroupEx-dividend date 2014
BerendsenEx-dividend date 2013
BodycoteEx-dividend date 2013
Charles TaylorEx-dividend date 2013
ChesnaraEx-dividend date 2013
Aberdeen UK Tracker TrustEx-dividend date 2013
EssentraEx-dividend date 2013
James Fisher and SonsEx-dividend date 2013
Galliford TryPayment date for 2014 dividend
esure GroupEx-dividend date 2013
Haynes PublishingPayment date for 2014 dividend
Henderson High Income TrustEx-dividend date 2014
JPMorgan American Investment TrustEx-dividend date 2013
JPMorgan Smaller Companies Investment TrustEx-dividend date 2013
IMIEx-dividend date 2013
Manchester & London Investment TrustEx-dividend date 2013
NorthamberEx-dividend date 2013
Secure Trust BankEx-dividend date 2013
RotorkEx-dividend date 2013
St IvesEx-dividend date 2013
St James's PlaceEx-dividend date 2013
Tamar European Industrial FundEx-dividend date 2013
TUI TravelEx-dividend date 2013
Ultra Electronics HoldingsEx-dividend date 2013
BBA AviationEx-dividend date 2013
EMIS GroupEx-dividend date 2013
IDOXEx-dividend date 2013
Rentokil InitialEx-dividend date 2013
Taylor WimpeyEx-dividend date 2013
The Vitec GroupEx-dividend date 2013
John Wood GroupEx-dividend date 2013
GKNEx-dividend date 2013
GreggsEx-dividend date 2013
Schroder Real Estate Investment TrustEx-dividend date 2014
Crest NicholsonEx-dividend date 2013
Stanley Gibbons GroupEx-dividend date 2014
QuindellEx-dividend date 2013
Photo-Me InternationalSpecial dividend payment date
BodycoteSpecial dividend payment date
esure GroupSpecial dividend payment date
Thursday, April 10 
Rio TintoPayment date for 2013 dividend
XP PowerPayment date for 2013 dividend
GlaxoSmithKlinePayment date for 2013 dividend
Wilmington GroupPayment date for 2014 dividend
  
Copyright 2014 Alliance News Limited. All Rights Reserved. 
  

More News
4 Apr 2024 00:03

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

NEW YORK, April 3 (Reuters) - Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.